These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33795524)

  • 21. How can Biology of Aging Explain the Severity of COVID-19 in Older Adults.
    Gallo A; Pero E; Pellegrino S; Macerola N; Murace CA; Ibba F; Agnitelli MC; Landi F; Montalto M
    Clin Geriatr Med; 2022 Aug; 38(3):461-472. PubMed ID: 35868666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is It "Aging" or Immunosenescence? The COVID-19 Biopsychosocial Risk Factors Aggravating Immunosenescence as Another Risk Factor of the Morbus. A Developmental-clinical Social Work Perspective.
    Chigangaidze RK; Chinyenze P
    J Gerontol Soc Work; 2021 Sep; 64(6):676-691. PubMed ID: 33975529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell population data: Could a routine hematology analyzer aid in the differential diagnosis of COVID-19?
    Lapić I; Brenčić T; Rogić D; Lukić M; Lukić I; Kovačić M; Honović L; Šerić V
    Int J Lab Hematol; 2021 Apr; 43(2):e64-e67. PubMed ID: 33079479
    [No Abstract]   [Full Text] [Related]  

  • 24. Aging impairs mitochondrial respiratory capacity in classical monocytes.
    Pence BD; Yarbro JR
    Exp Gerontol; 2018 Jul; 108():112-117. PubMed ID: 29655929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The aging of the immune system and its implications for transplantation.
    McGovern KE; Sonar SA; Watanabe M; Coplen CP; Bradshaw CM; Nikolich JŽ
    Geroscience; 2023 Jun; 45(3):1383-1400. PubMed ID: 36626019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
    Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
    Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals.
    Stanczak MA; Sanin DE; Apostolova P; Nerz G; Lampaki D; Hofmann M; Steinmann D; Krohn-Grimberghe M; Thimme R; Mittler G; Waller CF; Pearce EJ; Pearce EL
    Nat Commun; 2021 Apr; 12(1):2133. PubMed ID: 33837219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
    Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
    Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
    Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic characterization of COVID-19 patients with hematological cancer.
    Maia C; Martín-Sánchez E; Garcés JJ; De Cerio AL; Inogés S; Landecho MF; Gil-Alzugaray B; Perez C; Botta C; Zabaleta A; Alegre F; Rincón C; Blanco L; Sarvide S; Vilas-Zornoza A; Alignani D; Moreno C; Paiva A; Martinho A; Alves R; Colado E; Quirós C; Olid M; Blanco A; Argemi J; Paiva B; Yuste JR
    Haematologica; 2020 Dec; 106(5):1457-1460. PubMed ID: 33327714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter by Brambilla et al Regarding Article, "Monocyte-Mediated Thrombosis Linked to Circulating Tissue-Factor and Immune Paralysis in COVID-19".
    Brambilla M; Becchetti A; Nallio K; Camera M
    Arterioscler Thromb Vasc Biol; 2024 Sep; 44(9):e238-e239. PubMed ID: 39167674
    [No Abstract]   [Full Text] [Related]  

  • 34. How kids' immune systems can evade COVID.
    Nogrady B
    Nature; 2020 Dec; 588(7838):382. PubMed ID: 33303982
    [No Abstract]   [Full Text] [Related]  

  • 35. Response by Goonewardena et al to Letter Regarding Article, "Monocyte-Mediated Thrombosis Linked to Circulating Tissue Factor and Immune Paralysis in COVID-19".
    Goonewardena SN; Chen Q; Tate AM; Grushko OG; Damodaran Puthiya Veettil D; Blakely PK; Hayek SS; Pinsky DJ; Rosenson RS
    Arterioscler Thromb Vasc Biol; 2024 Sep; 44(9):e240-e241. PubMed ID: 39167673
    [No Abstract]   [Full Text] [Related]  

  • 36. Age- and Sex-Associated Variations in the Sensitivity of Serological Tests Among Individuals Infected With SARS-CoV-2.
    Vashisht R; Patel A; Crews BO; Garner OB; Dahm L; Wilson C; Butte AJ
    JAMA Netw Open; 2021 Feb; 4(2):e210337. PubMed ID: 33576815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 and Brain Aging: What are the Implications of Immunosenescence?
    Keller GS; Medeiros EB; Dos Santos MLC; Lidio AV; Kucharska E; Budni J
    Curr Aging Sci; 2023; 16(2):89-96. PubMed ID: 36579393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herd Immunity Against COVID-19: More Questions Than Answers.
    Russell RS
    Viral Immunol; 2021 May; 34(4):211-212. PubMed ID: 33999721
    [No Abstract]   [Full Text] [Related]  

  • 39. SARS-CoV-2-specific antibody rearrangements in prepandemic immune repertoires of risk cohorts and patients with COVID-19.
    Paschold L; Simnica D; Willscher E; Vehreschild MJ; Dutzmann J; Sedding DG; Schultheiß C; Binder M
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33064671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
    Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
    J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.